Cargando…
Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
The liver plays a central role in metabolism; however, xenobiotic metabolism variations between human hepatocytes and those in model organisms create challenges in establishing functional test beds to detect the potential drug toxicity and efficacy of candidate small molecules. In the emerging areas...
Autores principales: | Mancio-Silva, Liliana, Fleming, Heather E., Miller, Alex B., Milstein, Stuart, Liebow, Abigail, Haslett, Patrick, Sepp-Lorenzino, Laura, Bhatia, Sangeeta N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408324/ https://www.ncbi.nlm.nih.gov/pubmed/30840913 http://dx.doi.org/10.1016/j.cmet.2019.02.003 |
Ejemplares similares
-
Engineered Livers for Infectious Diseases
por: Gural, Nil, et al.
Publicado: (2017) -
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report
por: Norrito, Rosario Luca, et al.
Publicado: (2021) -
Engineering polyphenol-based carriers for nucleic acid delivery
por: Shui, Mingju, et al.
Publicado: (2023) -
From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization
por: Schlegel, Mark K, et al.
Publicado: (2022) -
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
por: Xiao, Yao, et al.
Publicado: (2018)